trending Market Intelligence /marketintelligence/en/news-insights/trending/rd43kr6gmafhbe45qqljdg2 content esgSubNav
In This List

Intec Pharma to delist shares from Tel Aviv bourse

Case Study

Identifying PPE Suppliers During the Pandemic

Blog

Highlighting the Top Regional Aftermarket Research Brokers by Sector Coverage

Video

COVID-19 Impact & Recovery: Healthcare Outlook for H2 2021

Blog

Corporate Credit Risk Trends in Developing Markets: A Loss Given Default (LGD) Perspective


Intec Pharma to delist shares from Tel Aviv bourse

Intec Pharma Ltd. will voluntarily delist its ordinary shares from the Tel Aviv Stock Exchange.

The delisting will take place in three months, with the shares continuing to trade on the exchange in the interim.

The Jerusalem-based drug developer's shares will remain listed on the Nasdaq Capital Market, and will transfer shares trading in Tel Aviv to the U.S. exchange.